Author:
YAGUCHI Shin-ichi,IZUMISAWA Yasuhiro,SATO Makoto,NAKAGANE Tsutomu,KOSHIMIZU Ichiro,SAKITA Katsuyasu,KATO Masanobu,YOSHIOKA Kimitomo,SAKATO Mitsuo,KAWASHIMA Seiichiro
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 1,3,5-Triazine as a promising scaffold in the development of therapeutic agents against breast cancer;European Journal of Medicinal Chemistry;2024-10
2. Design and Synthesis of 1,3,5-Triazines or Pyrimidines Containing Dithiocarbamate Moiety as PI3Kα Selective Inhibitors;ACS Medicinal Chemistry Letters;2023-08-09
3. Antitumor Activity of s-Triazine Derivatives: A Systematic Review;Molecules;2023-05-23
4. Based on 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474), design, synthesis and biological evaluation of novel PI3Kα selective inhibitors;Bioorganic Chemistry;2023-01
5. Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K/Akt/mTOR Pathway;International Journal of Molecular Sciences;2022-09-17